Loading...
Dernières publications
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
-
Elsa Lorthe, Laetitia Marchand-Martin, Mathilde Letouzey, Adrien M Aubert, Véronique Pierrat, et al.. Tocolysis after preterm prelabor rupture of membranes and 5-year outcomes: a population-based cohort study. American Journal of Obstetrics and Gynecology, 2024, 230 (5), ⟨10.1016/j.ajog.2023.10.010⟩. ⟨hal-04272387⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
82
Notices
64
Mots clés
Adjuvant
Clinical trials
Disinformation
Coronavirus
Immunogenicity
Antiviral agents
Chemotherapy
Risk factors
AstraZeneca vaccine
Delphi study
Clinical practice
Boys
Healthcare workers
Elderly
Respiratory syncytial virus
France
Alpha variant
Coadministration
Digital care
Immunocompromised
Attitudes of health personnel
Biomarkers
Vaccine hesitancy
Attitude to health
Influenza
DMD
Influenza-like illness
Practices
Cohort
Determinants
Incidence
Sleep
1790GAHB F
COVID-19
Adenoviral vector
Innate immunity
Care management
AON
Antiretroviral therapy
Vaccination
Deletion
Vaccine
Vaccine effectiveness
Antiviral
Immunization
Adults
Hospitalisations
Covidom
Confidence
Digital health intervention
SARS-CoV-2
Calcium phosphorus evaluation
Breakthrough infections
Bayes' theorem
Effectiveness
Older adults
HPV vaccine
Attitude
Cost of illness
Clinical skills
Adverse effects
COCONEL cohort surveys
Attitudes
ANTIRETROVIRAL THERAPY
Diabetes mellitus type 2
Data sharing
C-type lectin receptor
Vaccine acceptance
Awareness
Internet
CERVICOVAGINAL SECRETIONS
AIDS
Cystic fibrosis
COVID-19 mRNA vaccine
Cohort study
HIV
Epidemiology
Vaccine safety and efficacy
Clinical research
Acute kidney injury
Chronic kidney disease
Vaccines
Co-morbidities
Booster response
Dendritic cells
Determinant
COVID-19 vaccines
Efficacy
Conjugate pneumococcal vaccine
Catch-up
Assay
Conditional marketing authorization
Cancer
Dialysis
Covid 19
B-lymphocytes
Covid-19
Hesitancy
Misinformation
Antiviral therapy